Dark

ACRS
Aclaris Therapeutics, Inc.
stock NASDAQ

At Close

Jul 28, 2026 3:59:58 PM EDT

5.32USD-0.931%(-0.05)1,552,970

4.38Bid 6.26Ask 1.88Spread

Pre-market

0.00USD-100.000%(-5.23)0

After-hours

Jul 27, 2026 4:32:30 PM EDT

5.36USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

743.71M

CEO

Neal Walker

Headquarters

Wayne, Pennsylvania, USA

Industry

Diagnostics & Research

Next Earnings

Aug 6, 2026 (9d)

OMER XLV

ACRS Stats

Avg. Vol. 10 Day

1,994,287

Avg. Vol. 30 Day

2,079,572

Employees

Market Cap

743,709,096

Shares Out.

139,663,680

On/Off Exchange

60%/40%

6 Month Beta

1.75

1 Year Beta

0.50

2 Year Beta

0.86

3 Year Beta

0.97

52 Week Low

1.46

52 Week High

5.88

SMA50

4.91

SMA200

3.67

1 Week

-6.42%

1 Month

+6.08%

3 Month

+26.19%

6 Month

+51.71%

1 Year

+216.96%

2 Year

+300.38%

5 Year

-65.29%

Profile

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.

ACRS Stock Summary

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) stock price today is $5.32, and today's volume is 1,552,970. ACRS is down -0.931% today. The 30 day average volume is 2,079,572. ACRS market cap is 743.71M with 139,663,680 shares outstanding.